TrialPharmacoEconomics1997

Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.

C A Uyl-de Groot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.